123 related articles for article (PubMed ID: 16245268)
1. A novel injectable poly(epsilon-caprolactone)/calcium sulfate system for bone regeneration: synthesis and characterization.
La Gatta A; De Rosa A; Laurienzo P; Malinconico M; De Rosa M; Schiraldi C
Macromol Biosci; 2005 Nov; 5(11):1108-17. PubMed ID: 16245268
[TBL] [Abstract][Full Text] [Related]
2. Development of a new calcium sulphate-based composite using alginate and chemically modified chitosan for bone regeneration.
d'Ayala GG; De Rosa A; Laurienzo P; Malinconico M
J Biomed Mater Res A; 2007 Jun; 81(4):811-20. PubMed ID: 17236217
[TBL] [Abstract][Full Text] [Related]
3. Fabrication of injectable calcium sulfate bone graft material.
He Y; Gao J; Li X; Ma Z; Zhang Y; Li M; Zhang Y; Wang X; Qiu H; Liu Y
J Biomater Sci Polym Ed; 2010; 21(10):1313-30. PubMed ID: 20534187
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a novel poly(epsilon-caprolactone)-organosiloxane hybrid material for the potential application as a bioactive and degradable bone substitute.
Rhee SH; Lee YK; Lim BS; Yoo JJ; Kim HJ
Biomacromolecules; 2004; 5(4):1575-9. PubMed ID: 15244480
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterizations of biodegradable and crosslinkable poly(epsilon-caprolactone fumarate), poly(ethylene glycol fumarate), and their amphiphilic copolymer.
Wang S; Lu L; Gruetzmacher JA; Currier BL; Yaszemski MJ
Biomaterials; 2006 Feb; 27(6):832-41. PubMed ID: 16102819
[TBL] [Abstract][Full Text] [Related]
6. In vitro cytotoxicity of a novel injectable and biodegradable alveolar bone substitute.
Zhang Z; Feng X; Mao J; Xiao J; Liu C; Qiu J
Biochem Biophys Res Commun; 2009 Feb; 379(2):557-61. PubMed ID: 19116137
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable poly(epsilon-caprolactone) nanowires for bone tissue engineering applications.
Porter JR; Henson A; Popat KC
Biomaterials; 2009 Feb; 30(5):780-8. PubMed ID: 19012962
[TBL] [Abstract][Full Text] [Related]
8. Injectable calcium sulfate/mineralized collagen-based bone repair materials with regulable self-setting properties.
Chen Z; Liu H; Liu X; Cui FZ
J Biomed Mater Res A; 2011 Dec; 99(4):554-63. PubMed ID: 21936045
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization, and in vitro degradation of a biodegradable photo-cross-linked film from liquid poly(epsilon-caprolactone-co-lactide-co-glycolide) diacrylate.
Shen JY; Pan XY; Lim CH; Chan-Park MB; Zhu X; Beuerman RW
Biomacromolecules; 2007 Feb; 8(2):376-85. PubMed ID: 17291060
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization and thermal properties of chitin-g-poly(epsilon-caprolactone) copolymers by using chitin gel.
Jayakumar R; Tamura H
Int J Biol Macromol; 2008 Jul; 43(1):32-6. PubMed ID: 17950453
[TBL] [Abstract][Full Text] [Related]
11. Poly(3-hydroxybutyrate-co-3-hydroxyvalerate)/poly(epsilon-caprolactone) blends for tissue engineering applications in the form of hollow fibers.
Chiono V; Ciardelli G; Vozzi G; Sotgiu MG; Vinci B; Domenici C; Giusti P
J Biomed Mater Res A; 2008 Jun; 85(4):938-53. PubMed ID: 17896770
[TBL] [Abstract][Full Text] [Related]
12. Crosslinked poly(epsilon-caprolactone/D,L-lactide)/bioactive glass composite scaffolds for bone tissue engineering.
Meretoja VV; Helminen AO; Korventausta JJ; Haapa-aho V; Seppälä JV; Närhi TO
J Biomed Mater Res A; 2006 May; 77(2):261-8. PubMed ID: 16392138
[TBL] [Abstract][Full Text] [Related]
13. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
[TBL] [Abstract][Full Text] [Related]
14. In vitro/in vivo comparison of cefuroxime release from poly(ε-caprolactone)-calcium sulfate implants for osteomyelitis treatment.
Yaprakci V; Erdemli O; Kayabolen A; Tezcaner A; Bozkurt F; Keskin D
Biotechnol Appl Biochem; 2013; 60(6):603-16. PubMed ID: 23586705
[TBL] [Abstract][Full Text] [Related]
15. Release behaviors of porous poly(butylene succinate)/poly(epsilon-caprolactone) microcapsules containing indomethacin.
Park SJ; Lee YM; Hong SK
Colloids Surf B Biointerfaces; 2006 Feb; 47(2):211-5. PubMed ID: 16413177
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, material properties, and biocompatibility of a novel self-cross-linkable poly(caprolactone fumarate) as an injectable tissue engineering scaffold.
Jabbari E; Wang S; Lu L; Gruetzmacher JA; Ameenuddin S; Hefferan TE; Currier BL; Windebank AJ; Yaszemski MJ
Biomacromolecules; 2005; 6(5):2503-11. PubMed ID: 16153086
[TBL] [Abstract][Full Text] [Related]
17. Poly(ethylene glycol)/poly(epsilon-caprolactone) diblock copolymeric nanoparticles for non-viral gene delivery: the role of charge group and molecular weight in particle formation, cytotoxicity and transfection.
Jang JS; Kim SY; Lee SB; Kim KO; Han JS; Lee YM
J Control Release; 2006 Jun; 113(2):173-82. PubMed ID: 16750279
[TBL] [Abstract][Full Text] [Related]
18. The use of thermal treatments to enhance the mechanical properties of electrospun poly(epsilon-caprolactone) scaffolds.
Lee SJ; Oh SH; Liu J; Soker S; Atala A; Yoo JJ
Biomaterials; 2008 Apr; 29(10):1422-30. PubMed ID: 18096219
[TBL] [Abstract][Full Text] [Related]
19. Novel composite drug delivery system for honokiol delivery: self-assembled poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) micelles in thermosensitive poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) hydrogel.
Gong C; Shi S; Wang X; Wang Y; Fu S; Dong P; Chen L; Zhao X; Wei Y; Qian Z
J Phys Chem B; 2009 Jul; 113(30):10183-8. PubMed ID: 19572675
[TBL] [Abstract][Full Text] [Related]
20. Fabrication and characterization of poly(gamma-glutamic acid)-graft-chondroitin sulfate/polycaprolactone porous scaffolds for cartilage tissue engineering.
Chang KY; Cheng LW; Ho GH; Huang YP; Lee YD
Acta Biomater; 2009 Jul; 5(6):1937-47. PubMed ID: 19282262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
